Published in Transplantation on May 01, 1980
Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol (1988) 4.05
Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol (1988) 3.76
Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients. Transplantation (1989) 2.20
Functional studies on lymphocytes in adult human bone marrow. II. Isolated surface IgM-positive cells. J Immunol (1979) 1.70
Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization. Am J Dis Child (1993) 1.61
Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology (2000) 1.60
Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine (1997) 1.44
Rapid detection of infectious cytomegalovirus in blood with the aid of monoclonal antibodies. J Med Virol (1987) 1.42
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood (1994) 1.39
Phase I clinical and pharmacologic study of chronic oral administration of the farnesyl protein transferase inhibitor R115777 in advanced cancer. J Clin Oncol (2002) 1.22
Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen. Br Med J (1973) 1.16
Primary renal graft thrombosis. Nephrol Dial Transplant (1996) 1.16
Lymphocyte 5'-nucleotidase in primary hypogammaglobulinaemia and cord blood. Clin Exp Immunol (1980) 1.14
Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol (1990) 1.14
Cytomegalovirus (CMV) antigenemia: rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients. Transplant Proc (1989) 1.13
Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol (1995) 1.13
The human immune response to alpha-haemocyanin of Helix pomatia. Acta Med Scand (1973) 1.11
Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol (1978) 1.10
Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology (1990) 1.08
Is cytomegalovirus infection a major cause of T cell alterations after (autologous) bone-marrow transplantation? Lancet (1984) 1.07
Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response. J Hepatol (1989) 1.04
Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics (1989) 1.03
Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood (1997) 1.03
Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test. J Clin Microbiol (1992) 1.01
Associated expression of CD1 antigen and Fc receptor for IgE on epidermal Langerhans cells from patients with atopic dermatitis. Clin Exp Immunol (1988) 1.00
Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma. Thorax (1977) 0.99
Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol (1998) 0.99
The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ. Eur Urol (2002) 0.99
Pulmonary dysfunction is common during a cytomegalovirus infection after renal transplantation even in asymptomatic patients. Possible relationship with complement activation. Am Rev Respir Dis (1987) 0.97
Functional studies on lymphocytes in adult human bone marrow. I. Immunoglobulin production in vitro after fractionation on a sucrose gradient and T/non-T cell separation. J Immunol (1979) 0.95
Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease. Br J Haematol (1999) 0.94
Herpes-virus immunity and acute graft-versus-host disease. Lancet (1987) 0.93
Delay in platelet recovery after bone marrow transplantation: impact of cytomegalovirus infection. Blood (1985) 0.93
Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients. J Heart Transplant (1988) 0.93
Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients. Transplantation (1987) 0.92
Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N Engl J Med (1993) 0.92
Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation. Transpl Int (1992) 0.91
Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. Transplantation (1993) 0.91
Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial). Thorax (1978) 0.91
Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes. J Infect Dis (1992) 0.91
Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma. Melanoma Res (2003) 0.90
Acute humoral rejection after heart transplantation. Transplantation (1988) 0.89
Reversible stenosis of the renal artery in cadaver kidney grafts: a report of three cases. Clin Nephrol (1981) 0.88
Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation. Clin Exp Immunol (1989) 0.87
Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study. Transplantation (2000) 0.87
Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization. Cancer (1975) 0.87
PHA-induced cytotoxicity of human lymphocytes against adherent hela cells. J Immunol Methods (1978) 0.87
Vesicocalicostomy as ultimate solution for recurrent urological complications after cadaveric renal transplantation in a patient with poor bladder function. J Urol (1986) 0.87
Effect of supplementary vaccination in healthy non-responders to hepatitis B vaccination. Hepatogastroenterology (1988) 0.87
A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood (1990) 0.86
Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft. Blood (1985) 0.85
Induction of IgM production by pokeweed mitogen and interleukin-2: different responses by human peripheral blood cells and tonsil cells. Clin Immunol Immunopathol (1986) 0.85
Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma. Br J Cancer (2003) 0.85
Transplantation of contaminated organs. Br J Surg (1980) 0.83
Safe removal of failed transplanted kidneys. Br J Surg (1982) 0.83
Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients. Bone Marrow Transplant (1992) 0.83
Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT. Bone Marrow Transplant (1993) 0.83
Transplantation of cadaveric paediatric donor kidneys into adult recipients. Proc Eur Dial Transplant Assoc (1981) 0.83
Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism? J Am Soc Nephrol (1998) 0.83
Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation. Transplant Proc (1993) 0.83
Management of rupture in allografted kidneys. Neth J Surg (1980) 0.82
Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells. Leukemia (1998) 0.82
Cellular immunocompetence in asymptomatic paraproteinaemia. Acta Med Scand (1977) 0.82
Inflammatory demyelinating polyneuropathy in a kidney transplant patient with cytomegalovirus infection. Nephrol Dial Transplant (1999) 0.82
Hepatitis B surface antigen in environmental samples from hemodialysis units. J Infect Dis (1976) 0.82
Results of transplantation of kidneys from diabetic donors. Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.81
Evaluation of CD38 as target for immunotherapy in multiple myeloma. Blood (1995) 0.81
Influence of cytomegalovirus infection on the recovery of humoral immunity after autologous bone marrow transplantation. Exp Hematol (1987) 0.81
Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study. Cancer Immunol Immunother (2005) 0.81
Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood (1991) 0.81
The multifactorial etiology of graft-versus-host disease. Immunol Today (1987) 0.80
Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection. Clin Exp Immunol (1985) 0.80
HNK-1+ cells in non-Hodgkin's lymphoma: lack of relation with transferrin receptor expression on malignant cells. Br J Cancer (1985) 0.80
Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir. Bone Marrow Transplant (1989) 0.80
Pneumatosis intestinalis related to cytomegalo-virus infection--a new etiology? Eur J Radiol (1987) 0.80
Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppression. Clin Exp Immunol (1980) 0.80
Serology versus PCR-SSP in typing for HLA-DR and HLA-DQ: a practical evaluation. Tissue Antigens (1995) 0.80
Immunotherapeutic potential of bispecific antibodies. Immunol Today (1997) 0.80
Lysosomal enzymes in normal and leukemic B lymphocytes. Clin Chim Acta (1982) 0.80
Cytomegalovirus infection after renal transplantation. Pulmonary dysfunction measured by decreased diffusing capacity for carbon monoxide in patients with symptomatic and asymptomatic infection. Transplantation (1987) 0.80
Immune response in asymptomatic paraproteinemia. I. Primary and secondary antibody response to Helix pomatia hemocyanin. Scand J Immunol (1976) 0.80
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. Br J Cancer (1997) 0.80
Pneumatosis intestinalis in patients after cadaveric kidney transplantation. Possible relationship with an active cytomegalovirus infection. Transplantation (1984) 0.80
Successful regrafting of an explanted transplant kidney. Transplantation (1987) 0.80
Glycolytic enzymes of an erythroleukemic cell line, K562, before and after hemoglobin induction. Exp Hematol (1983) 0.80
Intensive cytoreductive therapy followed by autologous bone marrow transplantation for patients with hematologic malignancies or solid tumors. Cancer (1987) 0.80
Release of cytokines and soluble cell surface molecules by PBMC after activation with the bispecific antibody CD3 x CD19. Scand J Immunol (1997) 0.79
Human tonsil B lymphocyte function. II. Pokeweed mitogen-induced plasma cell differentiation of B cell subpopulations expressing multiple heavy chain isotypes on their surface. J Immunol (1984) 0.79
Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults. J Hepatol (1997) 0.79
Surface immunoglobulin restriction in B-non Hodgkin's lymphomas in cell suspension and on frozen tissue sections. Scand J Haematol (1985) 0.79
Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. Br J Haematol (1994) 0.79
Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins. Cancer Immunol Immunother (1996) 0.79
The primary immune response of patients with different stages of squamous-cell bronchial carcinoma. Thorax (1978) 0.79
Nitric oxide production and nitric oxide synthase expression in acute human renal allograft rejection. Transplantation (2000) 0.79
Impaired lymphocyte function and neutrophil damage during the first hours of hemodialysis. Clin Nephrol (1977) 0.79
[An adenovirus epidemic in patients with kidney transplantation]. Ned Tijdschr Geneeskd (1991) 0.78